Skip to main content
SpringerLink
Log in
Book cover

Periostin pp 145–159Cite as

Roles of Periostin in Asthma

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1132))

Abstract

Periostin is a matricellular protein that is deeply involved in type-2/eosinophilic airway inflammation and remodeling in asthma. While its expression in airway epithelial cells is correlated with the thickness of airway basement membrane, more importantly, periostin can be detected stably in blood with little variability, reflecting airway type-2 inflammation and remodeling. As for a result, serum periostin can serve as a valuable marker to identify patients with type-2 severe asthma who are insensitive to inhaled corticosteroids, and consequently have the excess decline of pulmonary function with asthma exacerbations. Serum periostin may significantly help to improve management of patients with severe asthma.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Chung KF, Wenzel SE, Brozek JL et al (2014) International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43:343–373

    Article  CAS  Google Scholar 

  2. Matsumoto H (2014) Serum periostin: a novel biomarker for asthma management. Allergol Int 63:153–160

    Article  CAS  Google Scholar 

  3. Izuhara K, Matsumoto H, Ohta S, Ono J, Arima K, Ogawa M (2015) Recent developments regarding periostin in bronchial asthma. Allergol Int 64(Suppl):S3–S10

    Article  Google Scholar 

  4. Izuhara K, Conway SJ, Moore BB et al (2016) Roles of periostin in respiratory disorders. Am J Respir Crit Care Med 193:949–956

    Article  CAS  Google Scholar 

  5. Yuyama N, Davies DE, Akaiwa M et al (2002) Analysis of novel disease-related genes in bronchial asthma. Cytokine 19:287–296

    Article  CAS  Google Scholar 

  6. Woodruff PG, Boushey HA, Dolganov GM et al (2007) Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A 104:15858–15863

    Article  CAS  Google Scholar 

  7. Lopez-Guisa JM, Powers C, File D, Cochrane E, Jimenez N, Debley JS (2012) Airway epithelial cells from asthmatic children differentially express proremodeling factors. J Allergy Clin Immunol 129:990–997. e996

    Article  CAS  Google Scholar 

  8. Peters MC, Mekonnen ZK, Yuan S, Bhakta NR, Woodruff PG, Fahy JV (2014) Measures of gene expression in sputum cells can identify T2-high and T2-low subtypes of asthma. J Allergy Clin Immunol 133:388–394

    Article  CAS  Google Scholar 

  9. Takayama G, Arima K, Kanaji T et al (2006) Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 118:98–104

    Article  CAS  Google Scholar 

  10. Komiya K, Ohta S, Arima K et al (2017) Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. Respir Res 18:37

    Article  Google Scholar 

  11. Makita K, Mikami Y, Matsuzaki H et al (2018) Mechanism of periostin production in human bronchial smooth muscle cells. Int Arch Allergy Immunol 175:26–35

    Article  CAS  Google Scholar 

  12. Shoda T, Futamura K, Kobayashi F, Saito H, Matsumoto K, Matsuda A (2013) Cell type-dependent effects of corticosteroid on periostin production by primary human tissue cells. Allergy 68:1467–1470

    Article  CAS  Google Scholar 

  13. Li W, Gao P, Zhi Y et al (2015) Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respir Res 16:57

    Article  Google Scholar 

  14. Sidhu SS, Yuan S, Innes AL et al (2010) Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A 107:14170–14175

    Article  CAS  Google Scholar 

  15. Kanemitsu Y, Ito I, Niimi A et al (2014) Osteopontin and periostin associate with a 20-year decline of pulmonary function in asthmatics. Am J Respir Crit Care Med 190:472–474

    Article  Google Scholar 

  16. Woodruff PG, Modrek B, Choy DF et al (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395

    Article  CAS  Google Scholar 

  17. Sehra S, Yao W, Nguyen ET et al (2011) Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation. J Immunol 186:4959–4966

    Article  CAS  Google Scholar 

  18. Gordon ED, Sidhu SS, Wang ZE et al (2012) A protective role for periostin and TGF-beta in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy 42:144–155

    Article  CAS  Google Scholar 

  19. Blanchard C, Mingler MK, McBride M et al (2008) Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol 1:289–296

    Article  CAS  Google Scholar 

  20. Bentley JK, Chen Q, Hong JY et al (2014) Periostin is required for maximal airways inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 134:1433–1442

    Article  CAS  Google Scholar 

  21. Johansson MW, Annis DS, Mosher DF (2013) Alpha (M)beta(2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin. Am J Respir Cell Mol Biol 48:503–510

    Article  CAS  Google Scholar 

  22. Johansson MW, Khanna M, Bortnov V, Annis DS, Nguyen CL, Mosher DF (2017) IL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration. Clin Exp Allergy 47:1263–1274

    Article  CAS  Google Scholar 

  23. Noguchi T, Nakagome K, Kobayashi T et al (2016) Periostin upregulates the effector functions of eosinophils. J Allergy Clin Immunol 138:1449–1452 e1445

    Article  CAS  Google Scholar 

  24. Kanemitsu Y, Matsumoto H, Izuhara K et al (2013) Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol 132:305–312. e303

    Article  CAS  Google Scholar 

  25. Matsusaka M, Kabata H, Fukunaga K et al (2015) Phenotype of asthma related with high serum periostin levels. Allergol Int 64:175–180

    Article  CAS  Google Scholar 

  26. James A, Janson C, Malinovschi A et al (2017) Serum periostin relates to type-2 inflammation and lung function in asthma: data from the large population-based cohort Swedish GA(2)LEN. Allergy 72:1753–1760

    Article  CAS  Google Scholar 

  27. Anderson HM, Lemanske RF, Jr., Arron JR, et al., Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma development. J Allergy Clin Immunol 2017; 139: 790–796

    Article  CAS  Google Scholar 

  28. Inoue T, Akashi K, Watanabe M et al (2016) Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allergy Immunol 27:521–526

    Article  Google Scholar 

  29. Song JS, You JS, Jeong SI et al (2015) Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy 70:674–681

    Article  CAS  Google Scholar 

  30. Arron JR, Izuhara K (2015) Asthma biomarkers: what constitutes a ‘gold standard’? Thorax 70:105–107

    Article  Google Scholar 

  31. Okamoto M, Hoshino T, Kitasato Y et al (2011) Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 37:1119–1127

    Article  CAS  Google Scholar 

  32. Palme S, Christenson RH, Jortani SA et al (2017) Multicenter evaluation of analytical characteristics of the Elecsys((R)) periostin immunoassay. Clin Biochem 50:139–144

    Article  CAS  Google Scholar 

  33. Corren J, Lemanske RF, Hanania NA et al (2011) Lebrikizumab treatment in adults with asthma. N Engl J Med 365:1088–1098

    Article  CAS  Google Scholar 

  34. Jia G, Erickson RW, Choy DF et al (2012) Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 130:647–654 e610

    Article  CAS  Google Scholar 

  35. Semprini R, Caswell-Smith R, Fingleton J et al (2017) Longitudinal variation of serum periostin levels in adults with stable asthma. J Allergy Clin Immunol 139:1687–1688. e1689

    Article  CAS  Google Scholar 

  36. Caswell-Smith R, Cripps T, Charles T et al (2017) Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma. Allergy, Asthma Clin Immunol 13:8

    Article  Google Scholar 

  37. Kuo CS, Pavlidis S, Loza M et al (2017) T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J 49:1602135

    Article  Google Scholar 

  38. Fingleton J, Braithwaite I, Travers J et al (2016) Serum periostin in obstructive airways disease. Eur Respir J 47:1383–1391

    Article  Google Scholar 

  39. Asano T, Kanemitsu Y, Takemura M et al (2017) Serum periostin as a biomarker for comorbid chronic rhinosinusitis in patients with asthma. Ann Am Thorac Soc 14:667–675

    Article  Google Scholar 

  40. Takahashi K, Meguro K, Kawashima H et al (2018) Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics. J Asthma 12:1–8

    Google Scholar 

  41. Hoshino M, Ohtawa J, Akitsu K (2016) Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma. Respirology 21:297–303

    Article  Google Scholar 

  42. Kimura H, Konno S, Makita H et al (2018) Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects. Allergol Int 67:357–363

    Article  CAS  Google Scholar 

  43. Bumbacea D, Campbell D, Nguyen L et al (2004) Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 24:122–128

    Article  CAS  Google Scholar 

  44. Nagasaki T, Matsumoto H, Kanemitsu Y et al (2014) Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes. J Allergy Clin Immunol 133:1474–1477. e1472

    Article  Google Scholar 

  45. Haldar P, Pavord ID, Shaw DE et al (2008) Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178:218–224

    Article  Google Scholar 

  46. Amelink M, de Nijs SB, de Groot JC et al (2013) Three phenotypes of adult-onset asthma. Allergy 68:674–680

    Article  CAS  Google Scholar 

  47. Nagasaki T, Matsumoto H, Kanemitsu Y et al (2014) Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma. Am J Respir Crit Care Med 190:1449–1452

    Article  Google Scholar 

  48. Dweik RA, Sorkness RL, Wenzel S et al (2010) Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 181:1033–1041

    Article  CAS  Google Scholar 

  49. Mansur AH, Srivastava S, Sahal A (2018) Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function. Respir Med 143:31–38

    Article  Google Scholar 

  50. Nagasaki T, Matsumoto H, Izuhara K (2017) Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma. Allergol Int 66:404–410

    Article  Google Scholar 

  51. Hinks TS, Brown T, Lau LC et al (2016) Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1. J Allergy Clin Immunol 138:61–75

    Article  CAS  Google Scholar 

  52. Sunadome H, Matsumoto H, Petrova G et al (2017) IL4Ralpha and ADAM33 as genetic markers in asthma exacerbations and type-2 inflammatory endotype. Clin Exp Allergy 47:998–1006

    Article  CAS  Google Scholar 

  53. Slager RE, Otulana BA, Hawkins GA et al (2012) IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor alpha antagonist. J Allergy Clin Immunol 130:516–522. e514

    Article  CAS  Google Scholar 

  54. Ishida A, Ohta N, Suzuki Y et al (2012) Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int 61:589–595

    Article  CAS  Google Scholar 

  55. Kimura H, Konno S, Nakamaru Y et al (2017) Sinus computed tomographic findings in adult smokers and nonsmokers with asthma. Analysis of clinical indices and biomarkers. Ann Am Thorac Soc 14:332–341

    Article  Google Scholar 

  56. Kim MA, Izuhara K, Ohta S et al (2014) Association of serum periostin with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 113:314–320

    Article  CAS  Google Scholar 

  57. Tajiri T, Matsumoto H, Hiraumi H et al (2013) Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma. Ann Allergy Asthma Immunol 110:387–388

    Article  CAS  Google Scholar 

  58. Mertens TCJ, van der Does AM, Kistemaker LE, Ninaber DK, Taube C, Hiemstra PS (2017) Cigarette smoke differentially affects IL-13-induced gene expression in human airway epithelial cells. Phys Rep 5:e13347

    Article  Google Scholar 

  59. Thomson NC, Chaudhuri R, Spears M, Haughney J, McSharry C (2015) Serum periostin in smokers and never smokers with asthma. Respir Med 109:708–715

    Article  Google Scholar 

  60. Shirai T, Hirai K, Gon Y, et al (2018) Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap. J Allergy Clin Immunol Pract. E-pub ahead of print

    Google Scholar 

  61. Carpaij OA, Muntinghe FOW, Wagenaar MB et al (2018) Serum periostin does not reflect type 2-driven inflammation in COPD. Respir Res 19:112

    Article  CAS  Google Scholar 

  62. Konstantelou E, Papaioannou AI, Loukides S et al (2017) Serum periostin in patients hospitalized for COPD exacerbations. Cytokine 93:51–56

    Article  CAS  Google Scholar 

  63. Caswell-Smith R, Hosking A, Cripps T et al (2016) Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease. Clin Exp Allergy 46:1303–1314

    Article  CAS  Google Scholar 

  64. James A, Ono J, Kupczyk M, Ohta S, Izuhara K, Dahlen SEK (2013) Controlled oral steroid intervention decreases serum periostin levels in asthmatic patients. Am J Respir Crit Care Med (Abstract) 187:A6005

    Google Scholar 

  65. Semprini R, Shortt N, Ebmeier S, et al (2018) Change in biomarkers of type-2 inflammation following severe exacerbations of asthma. Thorax. E-pub ahead of print

    Google Scholar 

  66. Kato G, Takahashi K, Izuhara K, Komiya K, Kimura S, Hayashi S (2013) Markers that can reflect asthmatic activity before and after reduction of inhaled corticosteroids: a pilot study. Biomark Insights 8:97–105

    Article  Google Scholar 

  67. Izuhara Y, Matsumoto H, Kanemitsu Y et al (2014) GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids. Allergy 69:668–673

    Article  CAS  Google Scholar 

  68. Hanania NA, Wenzel S, Rosen K et al (2013) Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med 187:804–811

    Article  CAS  Google Scholar 

  69. Tajiri T, Matsumoto H, Gon Y et al (2016) Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma. Allergy 71:1472–1479

    Article  CAS  Google Scholar 

  70. Caminati M, Gatti D, Dama A, Lorenzetti L, Senna G (2017) Serum periostin during omalizumab therapy in asthma: a tool for patient selection and treatment evaluation. Ann Allergy Asthma Immunol 119:460–462

    Article  Google Scholar 

  71. Hanania NA, Korenblat P, Chapman KR et al (2016) Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 4:781–796

    Article  CAS  Google Scholar 

  72. Liu Y, Zhang S, Chen R et al (2018) Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma. Allergy Asthma Proc 39:332–337

    Article  Google Scholar 

  73. Castro M, Corren J, Pavord ID et al (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378:2486–2496

    Article  CAS  Google Scholar 

  74. Simpson JL, Yang IA, Upham JW et al (2016) Periostin levels and eosinophilic inflammation in poorly-controlled asthma. BMC Pulm Med 16:67

    Article  Google Scholar 

  75. Carpagnano GE, Scioscia G, Lacedonia D et al (2018) Looking for airways periostin in severe asthma: could it be useful for clustering type 2 endotype? Chest 154:1083–1090

    Article  Google Scholar 

  76. Wardzynska A, Makowska JS, Pawelczyk M, Piechota-Polanczyk A, Kurowski M, Kowalski ML (2017) Periostin in exhaled breath condensate and in serum of asthmatic patients: relationship to upper and lower airway disease. Allergy, Asthma Immunol Res 9:126–132

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan

    Hisako Matsumoto

Authors
  1. Hisako Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hisako Matsumoto .

Editor information

Editors and Affiliations

  1. International Frontier, Tokyo Institute of Technology, Tokyo, Japan

    Akira Kudo

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Matsumoto, H. (2019). Roles of Periostin in Asthma. In: Kudo, A. (eds) Periostin. Advances in Experimental Medicine and Biology, vol 1132. Springer, Singapore. https://doi.org/10.1007/978-981-13-6657-4_15

Download citation

Publish with us

Policies and ethics

Search

Navigation